EMILIO
BOUZA SANTIAGO
Ikertzailea 2020-(e)ra arte
Holy Name Medical Center
Teaneck, Estados UnidosHoly Name Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2020
-
Exploratory evaluation of bezlotoxumab on outcomes associated with clostridioides difficile infection in MODIFY I/II Participants with Cancer
Open Forum Infectious Diseases, Vol. 7, Núm. 2
2017
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
New England Journal of Medicine, Vol. 376, Núm. 4, pp. 305-317